Daniel Bouthillier
Directeur Technique/Scientifique/R&D chez DEVONIAN HEALTH GROUP INC.
Profil
Daniel Bouthillier was the founder of Kaneq Bioscience Ltd.
(founded in 2012) where he held the title of President & Chief Executive Officer.
He is also the founder of Kaneq Pharma, Inc. Dr. Bouthillier's current jobs include Director positions at Québec Biotechnology Innovation Centre, Kanyr Pharma, Inc., and Vice President-Research at Devonian Health Group, Inc. His former jobs include Vice Chairman at Génome Québec, Inc., Executive Director-Global Facilities Management at Merck & Co., Inc. (from 2007 to 2010), and Senior Scientist & Head-Administrator at Clinical Research Institute of Montreal.
Dr. Bouthillier received a doctorate from the University of Montréal and an MBA from HEC Montréal.
Postes actifs de Daniel Bouthillier
| Sociétés | Poste | Début |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Directeur Technique/Scientifique/R&D | - |
Québec Biotechnology Innovation Centre
 Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Directeur/Membre du Conseil | - |
| Kanyr Pharma, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Bouthillier
| Sociétés | Poste | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/08/2010 |
Clinical Research Institute of Montreal
 Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Directeur Administratif | - |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Directeur/Membre du Conseil | - |
| Kaneq Pharma, Inc. | Fondateur | - |
Kaneq Bioscience Ltd.
 Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Directeur Général | - |
Formation de Daniel Bouthillier
| University of Montréal | Doctorate Degree |
| HEC Montréal | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Clinical Research Institute of Montreal
Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Commercial Services |
Québec Biotechnology Innovation Centre
Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Health Technology |
Kaneq Bioscience Ltd.
Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Health Technology |
| Kanyr Pharma, Inc. | |
| Kaneq Pharma, Inc. |